Novartis hopes new survival data will help its breast cancer drug Kisqali take on Pfizer\'s Ibrance. It probably won\'t. ASCO19 httpsbuff.ly2Mn1A0pÂ

Novartis hopes new survival data will help its breast cancer drug Kisqali take on Pfizer's Ibrance. It probably won't. #ASCO19 https://buff.ly/2Mn1A0p 

01:00 EDT 3 Jun 2019 | STAT

Novartis hopes new survival data will help its breast cancer drug Kisqali take on Pfizer's Ibrance. It probably won't. #ASCO19 https://buff.ly/2Mn1A0p 

More From BioPortfolio on "Novartis hopes new survival data will help its breast cancer drug Kisqali take on Pfizer's Ibrance. It probably won't. #ASCO19 https://buff.ly/2Mn1A0p "